Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Accumulated Expenses (2016 - 2026)

Argan's Accumulated Expenses history spans 16 years, with the latest figure at $40.7 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses fell 51.11% to $40.7 million in Q1 2026 year-over-year; TTM through Jan 2026 was $40.7 million, a 51.11% decrease, with the full-year FY2026 number at $40.7 million, down 51.11% from a year prior.
  • Accumulated Expenses hit $40.7 million in Q1 2026 for Argan, down from $67.1 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for AGX hit a ceiling of $83.3 million in Q1 2025 and a floor of $11.4 million in Q2 2023.
  • Historically, Accumulated Expenses has averaged $37.6 million across 5 years, with a median of $39.4 million in 2022.
  • Biggest five-year swings in Accumulated Expenses: tumbled 71.09% in 2023 and later soared 371.52% in 2024.
  • Tracing AGX's Accumulated Expenses over 5 years: stood at $40.2 million in 2022, then tumbled by 55.47% to $17.9 million in 2023, then grew by 29.12% to $23.1 million in 2024, then soared by 190.18% to $67.1 million in 2025, then tumbled by 39.33% to $40.7 million in 2026.
  • Business Quant data shows Accumulated Expenses for AGX at $40.7 million in Q1 2026, $67.1 million in Q4 2025, and $20.9 million in Q3 2025.